{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-002584","form_type":"8-K","ticker":"MLSS","cik":"0000855683","company_name":"MILESTONE SCIENTIFIC INC.","filed_at":"2023-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.264366+00:00","generated_at":"2026-06-20T00:39:39.189405+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Milestone Scientific appoints Peter Milligan as part-time CFO effective Feb 1, 2023","bullets":["Annual salary of $120,000 plus incentive bonus target of 40% of cash compensation payable in shares.","Eligible for $100,000 in annual restricted stock ($50k Feb 1, $50k Aug 1) valued at closing price, issued 60 days post-termination.","Milligan previously CFO at Melinta Therapeutics (led through Chapter 11), Exelis, and senior finance roles at ITT and AT&T."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-002584","json":"https://secwatch.observer/filing/0001437749-23-002584.json","markdown":"https://secwatch.observer/filing/0001437749-23-002584.md","text":"https://secwatch.observer/filing/0001437749-23-002584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/0001437749-23-002584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/mlss20230206_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T00:39:39.189405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c501defb0","claim":"Peter Milligan was appointed as Chief Financial Officer at MILESTONE SCIENTIFIC INC..","evidence_excerpt":"On February 6, 2023, Milestone Scientific Inc. (the “Company”) announced the appointment of Peter Milligan as the Company’s Chief Financial Officer, on a part-time basis, effective February1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/0001437749-23-002584-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}